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Introduction
In addition to malignant proliferating cells, tumors are also composed of numerous distinct non-cancerous cell types and activation states of those cell types. This notion, which is termed the tumor microenvironment, has been in the spotlight of research in recent years and is being further explored by novel techniques. The most studied set of non-cancerous cell types are the tumor-infiltrating lymphocytes (TILs). However, these TILs are only part of a variety of innate and adaptive immune cells, stroma cells and many other cell types that are found in the tumor and interact with the malignant cells. This complex and dynamic microenvironment is now recognized to be important both in promoting and inhibiting of tumor growth, invasion, and metastasis [1, 2] . Understanding the cellular heterogeneity composing the tumor microenvironment is key for improving existing treatments, the discovery of predictive biomarkers and development of novel therapeutic strategies.
Traditional approaches for dissecting the cellular heterogeneity in liquid tissues are difficult to apply in solid tumors [3] . Therefore, in the last decade, numerous methods have been published for digitally dissecting the tumor microenvironment using gene expression profiles [4] [5] [6] [7] (Reviewed in [8] ). Recently, multitudes of studies have been published applying published and novel techniques on publicly available resources of tumor samples such as The Cancer Genome Atlas (TCGA) [6, [9] [10] [11] [12] [13] . There are two general types of techniques: deconvolving the complete cellular composition, and assessing enrichments of individual cell types.
There are at least seven major concerns that the in silico methods could be prone to errors, and cannot reliably portray the cellular heterogeneity of the tumor microenvironment. First, current techniques depend on the expression profiles of purified cell types to identify reference genes and therefore rely heavily on the data source of which the references are inferred from, and could be inclined to overfitting to these data. Second, current methods portray only a very narrow perspective of the tumor microenvironment. The available methods usually focus on a subset of immune cell types, thus not accounting for the further richness of cell types in the microenvironment, including blood vessels and other different forms of cell subsets [14, 15] . A third problem is the ability of cancer cells to "imitate" other cell types by expressing immune-specific genes, such as macrophages-like expression pattern in tumors with parainflammation [16] ; only a few of the methods take this into account. Fourth, the ability of existing methods to estimate cell abundance have not yet been comprehensively validated in mixed samples. Cytometry is a common method for counting cell types in a mixture, and when performed in combination with gene expression profiling, can allow validation of the estimations. However, in most studies that included cytometry validation, these analyses were performed on only a very limited number of cell types and a limited number of samples [7, 13] .
A fifth challenge is that deconvolution approaches are prone to many different biases because of the strict dependencies among all cell types that are inferred. This could highly affect reliability in analyzing tumor samples, which are prone to form nonconventional expression profiles. A sixth problem has been raised with inferring an increasing number of closely related cell types [10] . Finally, deconvolution analysis heavily relies on the structure of the reference matrix, which limits its application to the resource used to develop the matrix. One such deconvolution approach is CIBESORT, which is the most comprehensive study to date, allowing the enumeration of 22 immune subsets [7] . Newman et al. performed adequate evaluation across data sources and validated the estimations using cytometry immunophenotyping. However, the shortcomings of deconvolution approaches are apparent in CIBERSORT, which is limited to Affymetrix microarray studies.
On the other hand, gene set enrichment analysis is a simple technique, which can be easily applied across data types and can be quickly applied for cancer studies. Each gene signature is used independently from all other signatures; thus it is protected from the limitations of deconvolution approaches. However, because of this independence, it is many times hard to differentiate between closely related cell types. In addition, gene signature-based methods only provide enrichment scores, and thus do not allow comparison across cell types, and cannot allow insights on the abundance of the cell type in the mixture.
Here, we present xCell, a novel method that integrates the advantages of gene set enrichment with deconvolution approaches. We present a compendium of newly generated gene signatures for 64 cell types, spanning multiple adaptive and innate immunity cells, hematopoietic progenitors, epithelial cells and extracellular matrix cells derived from thousands of expression profiles. Using in silico mixtures, we transform the enrichment scores to a linear scale, and using a spillover compensation technique we reduce dependencies between closely related cell types. We evaluate these adjusted scores in RNA-seq and microarray data from primary cell types samples from various independent sources. We examine their ability to digitally dissect the tumor microenvironment by in silico analyses, and perform the most comprehensive comparison to date with cytometry immunophenotyping. We compare our inferences with available methods and show that scores from xCell are more reliable in digital dissection of mixed tissues. Finally, we apply our method on TCGA tumor samples to portray a full tumor microenvironment landscape across thousands of samples. We provide these estimations to the community and hope that this resource will allow researchers gain a better perspective of the complex cellular heterogeneity in tumor tissues.
Results

Generating a gene signature compendium of cell-types
To generate our compendium of gene signatures for cell types, we collected gene expression profiles from six sources: the FANTOM5 project, from which we annotated 719 samples from 39 cell types analyzed by the Cap Analysis Gene Expression (CAGE) technique [17] ; the ENCODE project, from which we annotated 115 samples from 17 cell types analyzed by RNA-seq [18] ; the Blueprint project, from which we annotated 144 samples from 28 cell types analyzed by RNA-seq (http://www.blueprint-epigenome.eu/); the IRIS project, from which we annotated 95 samples from 13 cell types analyzed by Affymetrix microarrays [19] ; the Novershtern et al. study, from which we annotated 180 samples from 24 cell types analyzed by Affymetrix microarrays [20] ; and the Human Primary Cells Atlas (HPCA), a collection of Affymetrix microarrays composed of many different Gene Expression Omnibus (GEO) datasets, from which we annotated 569 Using the data source and based on different thresholds we learn gene signatures for 64 cell types. Of this collection of 5,327 signatures we choose 489 most reliable cell types, 3 for each cell types from each data source were it is available. The raw score is then the average ssGSEA score of all signatures corresponding to the cell type. Using simulations of gene expression for each cell type we learn a function to transform the non-linear association between the scores to a linear scale. Using the simulations we also learn the dependencies between cell types scores and apply a spillover compensation method to adjust the scores.
samples from 41 cell types [21] ( Figure 1A ). Altogether we collected and curated gene expression profiles from 1,822 samples of pure cell types, annotated to 64 distinct cell types and cell subsets ( Figure 1B and Supplementary Table 1 ). Of those, 54 cell types were found in at least 2 of these data sources.
Our strategy for selecting reliable cell type gene signatures is shown in Figure 1C (see Methods for full description and technical details). For each data source independently we identified genes that are overexpressed in one cell type compared to all other cell types. We applied different thresholds for choosing set of genes to represent the cell type gene signatures; hence from each source, we generated dozens of signatures per cell type. This scheme yielded 5,327 gene signatures corresponding to 64 cell types. Importantly, since our primary aim is to develop a tool for studying the cellular heterogeneity in the tumor microenvironment, we applied a methodology we previously developed [16] to filter out genes that tend to be overexpressed in a set of 634 carcinoma cell lines from the Cancer Cell Line Encyclopedia (CCLE) [22] .
Next, we used single-sample gene set enrichment analysis (ssGSEA) to score each sample based on all signatures. ssGSEA is a well-known method for aggregating a single score of the enrichment of a set of genes in the top of a ranked gene expression profile [23] . To choose the most reliable signatures we tested their performance in identifying the corresponding cell type in each of the data sources. To prevent overfitting, each signature learned from one data source was tested in other sources, but not in the data source it was originally inferred. To reduce biases resulting from a small number of genes and from the analysis of different platforms, instead of one signature per cell type, the top three ranked signatures from each data source were chosen. Altogether we generated 489 gene signatures corresponding to 64 cell types spanning multiple adaptive and innate immunity cells, hematopoietic progenitors, epithelial cells and extracellular matrix cells (Supplementary Table 2 ). The raw enrichment score per cell type is defined as the average ssGSEA scores from all the cell type's corresponding signature. Observing the scores in pure cell types affirmed their ability to identify the corresponding cell type compared to other cell types ( Supplementary Figure 1 ).
Spillover compensation between closely related cell types
Our primary objective is to accurately identify enrichments of cell types in mixtures. To imitate such admixtures, we performed an array of simulations of gene expression combinations of cell types to assess the accuracy and sensitivity of our gene signatures. We generated such in silico expression profiles using different data sources, including data that was not part of the signatures generation; using different sets of cell types in mixtures; and by choosing randomly one sample per cell type from all available samples in the data source. The simulations revealed that our raw scores reliably predict even small changes in the proportions of cell types, easily distinguish between most cell types, and are reliable in different transcriptomic analysis platforms (Supplementary Figure 2) . However, the simulations also revealed that raw scores of RNA-seq samples are not linearly associated with the abundance and that they do not allow comparisons across cell types ( Supplementary Figure 3) . Thus, using our simulations, we fit a formula that transforms the raw scores to cell-type abundances. We found that the transformed scores showed resemblance to the known fractions of the cell types in simulations, thus allowing to compare scores across cell types, and not just across samples (Supplementary Figure  4 ).
The simulations also revealed another limitation of the raw scores: closely related cell-types tend to have correlating scores ( Supplementary Figure 4) . That is, scores may show enrichment for a cell type due to a 'spillover effect' between closely related cell types. This problem mimics the spillover problem in flow-cytometry, in which fluorescent signals correlate with each other due to spectrum overlaps. Inspired by the compensations method used in flow-cytometry studies [24] , we leveraged our simulations to generate a spillover matrix that allows correcting for correlations between cell types. 
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We next compared the xCell scores with a set of 53 previously published signatures corresponding to 26 cell types [6, 12, 25, 26] (Supplementary Table 3 ). We applied each of the signatures in an array of simulations and compared their performance to estimate the simulated proportions ( Supplementary Figure 4) . Our analysis showed that xCell outperformed the previously published signatures in recapitulating the underlying abundances in 19 of the comparable cell types, only showing a slightly weaker ability to detect regulatory T-cells (Tregs) ( Figure 2B and Supplementary Figure 4 ). It should be noted that the signature that performed better is based on one gene, FOXP3, and it is not clear if this gene can reliably predict the Tregs abundance in real mixtures, especially in samples where activated T cells are abundant [27] . These simulated mixtures were all performed using the data sources that were also used for generating our signatures; thus for the next step, we employed an independent data source of multiple cell types that was not part of the development of the method (GSE60424) [28] . Again, xCell inferences of figure 4 . The first row corresponds to our inferences in predicting the underlying abundances of the cell types in the simulations (both color and pie chart correspond to average Pearson coefficients). Bindea, Charoentong, Palmer, Rooney and Tirosh represent sets of signatures for cell types from the corresponding manuscripts. Newman is the inferences produced using CIBERSORT on the simulations. Here the averages do not include the FANTOM5 simulations, since CIBERSORT was not able to recover any signal. In all cell types, except regulatory Tcells, our inferences outperform all other methods. C. A simulation analysis using GSE60424 as the data source, which was not part of the development of xCell. This data source contains 114 RNA-seq samples from 6 major immune cell types. Left: Correlation coefficients using our method before spillover adjustment and after the adjustment. Dependencies between CD4+ T-cells, CD8+ T-cells and NK cells were greatly reduced; spillover from monocytes to neutrophils was also removed. Right: Same as B, but only based on the simulations using GSE60424. Our method outperforms all other methods in all 6 cell types.
the underlying abundances of the simulated mixtures outperformed all other signatures ( Figure 2C ). Importantly, our compensation technique was able to completely remove associations between cell types, while previously published signatures showed considerate dependencies between closely related cell types, such as between CD8+ Tcells and NK cells (Supplementary Figure 5 ).
In addition, we also compared xCell with CIBERSORT, a prominent deconvolution-based method [7] . Unlike signature-based methods, which output independent enrichment scores per cell type, the output from deconvolution-based methods is the inferred proportions of the cell types in the mixture. The L22 reference matrix of CIBERSORT was only calibrated to work with Affymetrix microarrays, nevertheless, it also performed well in our simulations generated using RNA-seq data from Blueprint, but not when using data from FANTOM5 ( Supplementary Figure 4) . Similar to the performance compared to signatures, xCell also outperformed CIBERSORT enumerations across all cell types, using both Blueprint and GSE60424 as data sources ( Figure 2B -C and Supplementary Figure 4 ). xCell performed relatively well not just per cell types, but also in assessing proportions per sample, for example in a simulation using the Blueprint samples our scores showed a correlation of 0.67 on average across the 500 simulated mixtures compared to 0.44 using the CIBERSORT enumerations ( Supplementary Figure 4) .
Validation of enrichment scores with cytometry immunoprofilings
In addition to the simulated mixtures analysis, we compared our estimates for cell types enrichments from gene expression profiles with mass spectrometry (CyTOF) immunophenotyping. We utilized independent publicly-available studies, in which a total of 165 individuals were studied for both gene expression from whole blood and FACS across 18 cell subsets from peripheral blood mononuclear cells (PBMC) (available in ImmPort SDY311 and SDY420) [29] . We calculated xCell scores for each of the signatures using the study's expression profiles and correlated the scores with the FACS fractions of the cell subsets. Of the 14 cell types with at least 1% abundance, xCell was able to significantly recover 8 and 10 cell subsets in SDY311 and SDY420 respectively (Pearson correlation between calculated and actual cell counts p-value < 0.05) (Figure 3 ). Comparing the performance of xCell to previously published signatures and CIBERSORT revealed that no other method was able to recover cell types that our method was not able to recover in both data sets (Figure 3 ). In general, previous methods were able to recover signal only from major cell types, including B-cells, CD4+ and CD8+ T-cells, and monocytes, suggesting that their performance were not reliable in more specialized cell subsets. While our method also struggled in these cell subsets, it still showed significant correlations with most of the cell subsets, including effector memory CD8+ T-cells, naïve CD4+ T-cells and naïve B-cells. In addition, xCell was more reliable in CD4+ T-cells and monocytes and equally reliable in B-cells ( Figure 3) . In CD8+ T-cells xCell was outperformed by methods depending on solely on CD8A expression, which may not serve as a reliable biomarker in cancer settings (Supplementary Figure 6 ).
Newman et al. [7] generated a smaller dataset of 20 samples analyzed by both gene expression and cytometry (available at GSE65133). xCell recovered 7 of the 8 measurements (p-value < 0.05) and was significantly more reliable in 4 of the cell types ( Supplementary Figure 7) .
Despite the generally improved abilities of xCell to estimate cell populations, we do note that in some cases the correlations we observed were relatively low, emphasizing the difficulty of estimating cell subsets in mixed samples, and the need for cautious examination and further validation of findings.
Cell types enrichments in tumor samples
We next applied our methodology on 8,875 TCGA primary tumor samples from twentyfour cancer types. We used the expression profiles devised by Rahman et al. [30] , which include FPKM levels of twenty-two solid tumors and two liquid tumors ( Supplementary  Figure 8 ). Average scores of cell types in each cancer type affirmed our prior knowledge, validating the power of our method for identifying the cell type of origin of cancer types. As expected, epithelial cells were enriched in carcinomas, keratinocytes in squamous cell carcinomas, endothelial cells in clear cell carcinoma, hepatocytes in hepatocellular carcinoma, melanocytes in melanoma, B-cells in B-cells lymphoma, myeloid cells in AML and neurons in brain cancers ( Figure 4A ). While these results are expected, it is reassuring that xCell can be applied to and studied in human cancers. Most of the cell types we infer are part of the complex cellular heterogeneity of the tumor microenvironment. We hypothesized that an additive combination of all cell types' scores would be negatively correlated with tumor purity. Thus, we generated a microenvironment score as the sum of all immune and stroma cell types. We then correlated this microenvironment score with our previously generated purity estimations, which are based on copy number variations, gene expression, DNA methylation and H&E slides [31] . Our analysis showed highly significant negative correlations in all cancer types, suggesting this score as a novel measurement for tumor microenvironment abundance ( Supplementary Figure 9 ). Finally, to provide insights into the potential of xCell to portray the tumor microenvironment, we plot all tumor samples based on their cell types scores. Using different sets of cell types inferences, we applied the t-Distributed Stochastic Neighbor Embedding (t-SNE) dimensionality reduction technique [32] (Supplementary Figure 10) . Interestingly, the analysis revealed that unique microenvironment compositions characterize different cancer indications. For example, prostate cancer samples are easily distinguished based on their myeloid cell types composition, a unique lymphoid composition characterizes kidney cancers. Performing the analysis with all immune and stroma cell types revealed clear clusters distinguishing between most of the cancer types ( Figure 4B ), suggesting that the microenvironment composition uniquely characterizes cancer types. This notion emphasizes the importance of portraying the full cellular heterogeneity of the tumor microenvironment for the study of cancer. To this end, we calculated the enrichment scores for 64 cell types across the TCGA spectrum, and provide this data with the hope that it will serve the research community as a resource to further explore novel associations of cell types enrichment in human tumors (Supplementary Table 4 ).
Discussion
Recently, many studies have shown different methodologies for digital dissection of cancer samples [3, 6, [9] [10] [11] [12] [13] . These studies have suggested novel insights in cancer research and related to therapy efficacy. However, it is important to remember that the methods that have been applied for portraying the tumor microenvironment have only retained limited validation, and it is unclear how reliable their estimations are. In this study, we took a step back and focused on generating cell type gene scores that could reliably estimate enrichments of cell types. Our method, which is gene-signature based, is more reliable due to its reliance on a group of signatures for each cell type, learned from multiple data sources, which increases the ability to detect the signal from the noise. Our method also integrates a novel approach to remove dependencies between cell types, which allow better reliability in studying closely related cell types.
To develop xCell, we collected the most comprehensive resource to date of primary cell types, spanning the largest set of human cell types. We then performed an extensive validation of the predicted cell types inferences in mixed samples. Our method for choosing a set of signatures that are reliable across several data sources has proven to be beneficial, as our scores robustly outperformed all available methods in predicting the abundance of cell types in in silico mixtures and blood samples. Based on our evaluation, xCell provides the most accurate and sensitive way to identify enrichments of many cell types in an admixture, allowing the detection of subtle differences in the enrichments of a particular cell type in the tumor microenvironment with high confidence.
We chose to apply a gene signature enrichment approach over deconvolution methods because of several advantages that the former provides. First, gene signatures are rank-based, and therefore are suitable for cross-platform transcriptome measurements. We showed here that our scores reliably predict enrichments in different RNA-seq techniques and different microarrays platforms. They are agnostic to normalization methods or concerns related to batch effects, making them robust to both technical and biological noise. Second, there is no decline in performance with increasing number of cell types. The tumor microenvironment is a rich milieu of cell types, and our analyses show enrichments of many mesenchymal derived cells in the tumors. A partial portrayal of the tumor microenvironment may result in misleading findings. Finally, gene signatures are simple and can easily be adjusted.
The main disadvantage of gene signatures is their difficulty to discriminate closely related cell types, though it is not clear how well other methods can distinguish such cell types as well [10] . Our method takes this into account and uses a novel technique, inspired by flow cytometry analyses, to remove such dependencies between closely related cell types. It is important to note that until this step the cell types scores are independent of each other, and a deflection of genes of one cell type will not harm all other cell types. However, the 'spillover correction' adjustment removes this strict independence between cell types inferences as in deconvolution methods. While our method only compensates between closely related cell types and is, therefore, most of the inferences are still independent, the results should yet be cautiously analyzed.
Despite the utility of our signatures for characterizing the tumor microenvironment, several issues require further investigation. While our signatures outperformed previous methods, it is important to note that our correlations were still far from perfect with direct measurements. More expression data from pure cell types, especially cell types with limited samples, and more expression data coupled with cytometry counts from various tissue types will allow defining signatures more precisely and in turn, allow better reliability. Meanwhile, it is necessary to refer to inferences made by our method or other methods with a grain of salt. Discoveries made using digital dissection methods must be rigorously validated using other technologies to avoid hasty conclusions.
In summary, tissue dissection methods are an emerging tool for large-scale characterization of the tumor cellular heterogeneity. These approaches do not rely on tissue dissociation, opposed to single-cell techniques, and therefore provide an effective tool for dissecting solid tumors. The immense availability of public gene expression profiles allows these methods to be efficiently performed on hundreds of historical cohorts spanning thousands of patients, and to associate them with clinical outcomes. Here we presented the most comprehensive collection of gene expression enrichment scores for cell types. Our methodology for generating cell type enrichment scores and adjusting them to cell types proportions allowed us to create a powerful tool that is the most reliable and robust tool currently available for identifying cell types across data sources. We provide a simple web tool to the community and hope that further studies will utilize it for the discovery of novel predictive and prognostic biomarkers, and new therapeutic targets: http://xCell.ucsf.edu/.
Methods
Data sources
Signatures data sources: RNA-seq and cap analysis gene expression (CAGE) normalized FPKM were downloaded from the FANTOM5, ENCODE and Blueprint data portals. Raw Affymetrix microarray CEL files were downloaded from the Gene Expression Omnibus (GEO), accessions: GSE22886 (IRIS), GSE24759 (Novershtern) and GSE49910 (HPCA), and analyzed using the Robust Multi-array Average (RMA) procedure on probe-level data using Matlab functions. The analysis was performed using custom CDF files downloaded from Brainarray [33] . All samples were manually annotated to 64 cell types ( Supplementary Table 1 ).
Other expression data sources: RNA-seq normalized counts were downloaded from the gene expression omnibus (GEO) accession GSE60424. Illumina HumanHT-12 V4.0 beadchip data of PBMC samples and the accompanying CyTOF data were downloaded from ImmPort accession SDY311, and quantile normalized using Matlab functions. Similarly, Agilent Whole Human Genome 4 x 44 K slides data of PBMC samples and the accompanying CyTOF data were downloaded from ImmPort accession SDY420 [34] , and quantile normalized using Matlab functions. Multiple probes per gene were collapsed using averages. RNA-seq data of Cancer Cell Line Encyclopedia (CCLE) [22] was obtained using the PharmacoGx R package [35] . FPKM levels of 9,264 TCGA samples were downloaded from GEO accession GSE62944, and non-primary tumor samples were removed.
Published signatures were collected from their corresponding papers [6, 12, 25, 26] . (Supplementary Table 3 ).
In silico mixtures
The simulations were performed as following: A mixture set contains 500 mixtures (simulated expression profiles) that were generated using one of the data sources. First, we choose a representative group of cell types available in the data. Second, in each of the mixtures we randomly chose one sample for each cell type to represent the expression profile of the cell type. This random selection introduces significant noise to the mixture, and between mixtures in the mixture set, which reflect the variation we observe between real datasets. We then randomly choose a fraction for each of the cell types (the fractions sum to 1). The expression profile of each cell type is multiplied by its corresponding fraction, and the expression profile of the mixture is the sum of all cell types. This process is repeated 500 times to create 500 distinct mixtures using same set of cell types. We also created simulated mixtures that use the median expression profile of a cell type instead of choosing randomly one of the samples. This creates significantly homogenous and noiseless mixture, and the signatures can precisely identify small differences.
The xCell pipeline
Filtering cancer genes: In a previous study [16] we calculated using CCLE the number of cell lines that are over-expressing each gene (2-fold more than the peak of expression distribution). For generating the signatures we only use genes that have an overexpression rate of less than 5% (less than 32 cell lines of the 634 carcinoma cell lines). We use this stringent threshold to eliminate genes that tend to be overexpressed in tumors, regardless of the cellular composition. Of 18,988 genes analyzed, 9,506 genes were identified as not overexpressing in tumors. For signatures of cell types that may be the cell of origin of solid tumors, including epithelial cells, sebocytes, keratinocytes, mesangial cells, hepatocytes, melanocytes, astrocytes and neurons we used all genes.
Generating gene signatures:
Expression profiles were reduced to 10,782 genes that are shared across all 6 data sources. Gene expression was converted to log scale by adding 3
